Table 3 Oct-4 expression – cycle characteristics
From: Markers of stem cells in human ovarian granulosa cells: is there a clinical significance in ART?
Οct-4 expression | p-value* | ||
|---|---|---|---|
Yes median (IQR) | No median (IQR) | ||
Age (ys) | 36.00 (35.00, 38.00) | 36.00 (30.00, 37.00) | 0.520 |
BMI | 23.20 (19.80, 24.60) | 22.80 (20.10, 26.30) | 0.778 |
Serum FSH (IU/L) | 6.30 (5.80, 7.50) | 5.90 (4.30, 8.10) | 0.545 |
SerumLH (IU/L) | 4.50 (3.40, 4.60) | 5.70 (3.40, 9.70) | 0.165 |
SerumPRL (ng/ml) | 11.40 (9.70, 15.30) | 10.40 (5.50, 25.10) | 0.790 |
Total gonadotropin dose | 2,675.00 (1800.0, 3200.0) | 3,112.50 (2325.00, 3675.00) | 0.364 |
Duration of stimulation (ds) | 10.00 (9.00, 11.00) | 10.00 (9.00, 11.00) | 1.000 |
Serum estradiol on the 5th day of rFSH administration (pg/ml) | 500.00 (350.00, 758.00) | 455.00 (180.00, 890.00) | 0.805 |
Serum estradiol on the day of hCG administration (pg/ml) | 1,800.00 (1,200.00, 2,025.00) | 2,283.50 (1,828.00, 2,617.00) | 0.149 |
No of follicles aspirated | 8.00 (6.00, 10.00) | 8.50 (6.00, 10.00) | 0.972 |
No of oocyte retrieved | 8.00 (6.00, 9.00) | 8.00 (6.00, 10.00) | 0.887 |
Mature oocytes ratio (%) | 75.00 (67.00, 80.0) | 68.5 (67.0, 78.0) | 0.415 |